Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis

被引:12
作者
Yan, Lizhao [1 ]
Gao, Nan [1 ]
Ai, Fangxing [1 ]
Zhao, Yingsong [2 ]
Kang, Yu [1 ]
Chen, Jianghai [1 ]
Weng, Yuxiong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hand Surg, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
国家重点研发计划;
关键词
chondrosarcoma; survival analysis; machine learning; DeepSurv; deep learning; NOMOGRAM;
D O I
10.3389/fonc.2022.967758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundAccurate prediction of prognosis is critical for therapeutic decisions in chondrosarcoma patients. Several prognostic models have been created utilizing multivariate Cox regression or binary classification-based machine learning approaches to predict the 3- and 5-year survival of patients with chondrosarcoma, but few studies have investigated the results of combining deep learning with time-to-event prediction. Compared with simplifying the prediction as a binary classification problem, modeling the probability of an event as a function of time by combining it with deep learning can provide better accuracy and flexibility. Materials and methodsPatients with the diagnosis of chondrosarcoma between 2000 and 2018 were extracted from the Surveillance, Epidemiology, and End Results (SEER) registry. Three algorithms-two based on neural networks (DeepSurv, neural multi-task logistic regression [NMTLR]) and one on ensemble learning (random survival forest [RSF])-were selected for training. Meanwhile, a multivariate Cox proportional hazards (CoxPH) model was also constructed for comparison. The dataset was randomly divided into training and testing datasets at a ratio of 7:3. Hyperparameter tuning was conducted through a 1000-repeated random search with 5-fold cross-validation on the training dataset. The model performance was assessed using the concordance index (C-index), Brier score, and Integrated Brier Score (IBS). The accuracy of predicting 1-, 3-, 5- and 10-year survival was evaluated using receiver operating characteristic curves (ROC), calibration curves, and the area under the ROC curves (AUC). ResultsA total of 3145 patients were finally enrolled in our study. The mean age at diagnosis was 52 +/- 18 years, 1662 of the 3145 patients were male (53%), and mean survival time was 83 +/- 67 months. Two deep learning models outperformed the RSF and classical CoxPH models, with the C-index on test datasets achieving values of 0.832 (DeepSurv) and 0.821 (NMTLR). The DeepSurv model produced better accuracy and calibrated survival estimates in predicting 1-, 3- 5- and 10-year survival (AUC:0.895-0.937). We deployed the DeepSurv model as a web application for use in clinical practice; it can be accessed through https://share.streamlit.io/whuh-ml/chondrosarcoma/Predict/app.py. ConclusionsTime-to-event prediction models based on deep learning algorithms are successful in predicting chondrosarcoma prognosis, with DeepSurv producing the best discriminative performance and calibration.
引用
收藏
页数:13
相关论文
共 29 条
  • [1] Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis
    Amer, Kamil M.
    Munn, Murty
    Congiusta, Dominick
    Abraham, John A.
    Mallick, Atrayee Basu
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2020, 38 (02) : 311 - 319
  • [2] Clinical outcome of central conventional chondrosarcoma
    Angelini, Andrea
    Guerra, Giovanni
    Mavrogenis, Andreas F.
    Pala, Elisa
    Picci, Piero
    Ruggieri, Pietro
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (08) : 929 - 937
  • [3] How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers, Michiel E. R.
    Karhade, Aditya, V
    Setola, Elisabetta
    Gambarotti, Marco
    Groot, Olivier Q.
    Erdogan, Kivilcim E.
    Picci, Piero
    Donati, Davide M.
    Schwab, Joseph H.
    Palmerini, Emanuela
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2020, 478 (10) : 2300 - 2308
  • [4] Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation
    Bongers, Michiel E. R.
    Thio, Quirina C. B. S.
    Karhade, Aditya, V
    Stor, Merel L.
    Raskin, Kevin A.
    Calderon, Santiago A. Lozano
    DeLaney, Thomas F.
    Ferrone, Marco L.
    Schwab, Joseph H.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2019, 477 (10) : 2296 - 2303
  • [5] Chondrosarcoma of bone: An oncological and functional follow-up study
    Bruns, J
    Elbracht, M
    Niggemeyer, O
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (06) : 859 - 864
  • [6] Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis
    Cranmer, Lee D.
    Chau, Bonny
    Mantilla, Jose G.
    Loggers, Elizabeth T.
    Pollack, Seth M.
    Kim, Teresa S.
    Kim, Edward Y.
    Kane, Gabrielle M.
    Thompson, Matthew J.
    Harwood, Jared L.
    Wagner, Michael J.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2022, 480 (04) : 748 - 758
  • [7] A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma
    Dong, Yimin
    Xie, Linka
    Kang, Honglei
    Peng, Renpeng
    Guo, Qian
    Song, Kehan
    Wang, Jai
    Guan, Hanfeng
    Fang, Zhong
    Li, Feng
    [J]. SPINE, 2021, 46 (22) : E1192 - E1201
  • [8] Fotso Stephane, 2018, Deep Neural Networks for Survival Analysis Based on a MultiTask Framework
  • [9] MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones
    Gitto, Salvatore
    Cuocolo, Renato
    van Langevelde, Kirsten
    van de Sande, Michiel A. J.
    Parafioriti, Antonina
    Luzzati, Alessandro
    Imbriaco, Massimo
    Sconfienza, Luca Maria
    Bloem, Johan L.
    [J]. EBIOMEDICINE, 2022, 75
  • [10] CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas
    Gitto, Salvatore
    Cuocolo, Renato
    Annovazzi, Alessio
    Anelli, Vincenzo
    Acquasanta, Marzia
    Cincotta, Antonino
    Albano, Domenico
    Chianca, Vito
    Ferraresi, Virginia
    Messina, Carmelo
    Zoccali, Carmine
    Armiraglio, Elisabetta
    Parafioriti, Antonina
    Sciuto, Rosa
    Luzzati, Alessandro
    Biagini, Roberto
    Imbriaco, Massimo
    Sconfienza, Luca Maria
    [J]. EBIOMEDICINE, 2021, 68